The invention belongs to the biomedical engineering field, in particular relating to a novel targeted microbubble contrast agent.
本发明属于生物医学工程领域，更具体地说，本发明涉及一种新型靶向微泡造影剂。
Objective To prepare an ultrasound microbubble contrast agent using PLLA-PEG-PLLA copolymer as the shell material, and test their acoustic characteristics in vitro.
目的用PLLA - PEG - plla共聚物为外壳材料制备微泡造影剂，建立体外声学性质测定装置和方法。
Resently years, researchers utilize biological effects generated by microbubble contrast agent combined ultrasound techniques to implement therapy of tumor by microbubble carrying drug and gene.
近几年，国内外学者利用超声联合微泡造影技术所产生的生物学效应，实现了微泡造影剂携载药物和基因对肿瘤的靶向治疗。
ABSTRACT: Objective To prepare polyelectrolyte multilayer film-coated microbubble ultrasound contrast agent (UCA) and evaluate its effects in contrast imaging on normal rabbit's liver parenchyma.
摘要：目的制备多层聚电解质膜包覆的微泡超声造影剂，观察其对正常兔肝脏超声显影效果。
Microbubble may be a vector for target treatment. Therefore, ultrasound contrast agent as an new and non-invasive vector for treatment holds considerable promises.
微泡可能成为靶向治疗的载体，超声造影剂作为一种新型、无创的运载系统具有广阔的应用前景。
Microbubble may be a vector for target treatment. Therefore, ultrasound contrast agent as an new and non-invasive vector for treatment holds considerable promises.
微泡可能成为靶向治疗的载体，超声造影剂作为一种新型、无创的运载系统具有广阔的应用前景。
应用推荐